BioSpace News Archive

Meristem announced here today the commercial launch of two patent-pending biological delivery systems – BIO-CAPSULE™ and MICROBILIZE™ – building on their effort to bring real productivity gains to farmers.

Secant Group has signed an agreement with The Abigail Wexner Research Institute at Nationwide Children’s Hospital in Columbus, OH, to explore potential solutions for repairing congenital heart defects in children.

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “TELO”) is pleased to announce that the initial clinical validation stage of its ongoing clinical study for smoldering multiple myeloma (“SMM”), in collaboration with the Mayo Clinic, has completed review and analysis of its first cohort, consisting of 187 patients and has exceeded its targeted endpoints.

Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner.

The global cell lysis and disruption market is expected to witness moderate growth during the forecast period between 2021 and 2031.

The acute repetitive seizure is a condition that occurs in patients with drug-refractory epilepsy. It is also known as cluster seizure, seizure flurry, breakthrough seizure, seizure cluster, serial seizure, or prolonged seizure.

Biolojic Design, a pioneer in the use of artificial intelligence (AI) in antibody design, today announced the appointment of Ronald Herbst , Ph.D. as Chief Scientific Officer, effective October 3 , 2022.

Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering.

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the following virtual investor conferences in September.

Pardes Biosciences, Inc. today announced the appointments of Laurie Smaldone Alsup, M.D. and John C. Pottage, Jr., M.D. to its Board of Directors.